OBJECTIVE Examine the 10-year trend in the prevalence and treatment of diabetic macular
edema (DME) and vision-threatening diabetic retinopathy (VTDR) among commercially …

Importance While diabetes prevalence among US adults has increased in recent decades,
few studies document trends in diabetes-related eye disease. Objective To examine 10-year …

Purpose To evaluate how the monitoring and treatment for diabetic macular edema (DME)
has changed in a national sample. Design Retrospective cohort study. Methods Setting …

BACKGROUND AND OBJECTIVE: To characterize vascular endothelial growth factor
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …

Diabetic retinopathy (DR) is both the leading cause of blindness among adults aged 20 to
74 in the United States, and the leading ocular complication associated with diabetes …

BACKGROUND AND OBJECTIVE: Although people of low socioeconomic status (SES) and
certain racial groups are at greater risk of developing diabetic macular edema (DME), the …

Importance Thickening of the center of the retina, diabetic macular edema (DME), is the most
common cause of visual loss due to diabetes mellitus. Treatment of DME has improved …

Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population.
However, there is limited understanding of the epidemiology of DME with visual impairment …

Objectives To characterize diabetic macular edema (DME) treatment patterns in Taiwan and
examine their impact on health care resource utilization and visual and anatomic outcomes …

BACKGROUND: Diabetic macular edema (DME) is a form of diabetic retinopathy caused by
continued leakage from retinal blood vessels. The use of anti-vascular endothelial growth …